Q3 2025 Holdings
Filed 2025-11-14 | 115 holdings | $474.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $30.4M | 1,507,025 | 6.4% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $22.8M | 157,400 | 4.8% |
| Tower Semiconductor LTD(TSEM) | SHS NEW | M87915274 | $22.5M | 311,802 | 4.8% |
| Merus N VCall | COM | N5749R100 | $14.1M | 150,000 | 3.0% |
| Nova LTD(NVMI) | COM | M7516K103 | $14.0M | 43,896 | 3.0% |
| Invesco QQQ TR(QQQ) | UNIT SER 1 | 46090E103 | $13.8M | 22,960 | 2.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $11.6M | 82,738 | 2.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $10.6M | 352,558 | 2.2% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $10.4M | 135,060 | 2.2% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $10.4M | 219,515 | 2.2% |
| Cidara Therapeutics Inc(CDTX)Call | COM NEW | 171757206 | $9.6M | 100,000 | 2.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $8.9M | 161,517 | 1.9% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $8.3M | 219,910 | 1.8% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $7.8M | 991,142 | 1.6% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $7.7M | 10,040 | 1.6% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $7.6M | 40,831 | 1.6% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $7.3M | 75,743 | 1.5% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $7.1M | 474,309 | 1.5% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $6.8M | 130,000 | 1.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $6.0M | 387,716 | 1.3% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $5.9M | 643,957 | 1.2% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $5.9M | 105,677 | 1.2% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $5.8M | 25,256 | 1.2% |
| Cellebrite DI LTD(CLBT) | ORDINARY SHARES | M2197Q107 | $5.5M | 298,948 | 1.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $5.5M | 1,794,387 | 1.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $5.4M | 426,518 | 1.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $5.4M | 207,764 | 1.1% |
| Solaredge Technologies Inc | NOTE 2.250% 7/0 | 83417MAE4 | $5.3M | 4,000,000 | 1.1% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $5.3M | 122,000 | 1.1% |
| Solaredge Technologies Inc(SEDG) | COM | 83417M104 | $5.2M | 140,966 | 1.1% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $5.2M | 431,693 | 1.1% |
| Immatics N.v(IMTX) | SHS | N44445109 | $5.0M | 583,105 | 1.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $4.9M | 173,931 | 1.0% |
| Savara Inc(SVRA) | COM | 805111101 | $4.8M | 1,350,333 | 1.0% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $4.7M | 37,000 | 1.0% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $4.7M | 157,533 | 1.0% |
| Uniqure NV(QURE)Put | SHS | N90064101 | $4.4M | 75,000 | 0.9% |
| Varonis SYS Inc(VRNS) | COM | 922280102 | $4.2M | 73,900 | 0.9% |
| Ishares TR(TLT)Call | 20 YR TR BD ETF | 464287432 | $4.2M | 47,000 | 0.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $4.1M | 256,743 | 0.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $4.1M | 48,600 | 0.9% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $4.0M | 154,343 | 0.8% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $3.4M | 504,409 | 0.7% |
| Elbit SYS LTD(ESLT) | ORD | M3760D101 | $3.4M | 6,740 | 0.7% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $3.4M | 363,947 | 0.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $3.4M | 166,765 | 0.7% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $3.3M | 185,270 | 0.7% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $3.3M | 1,280,233 | 0.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $3.2M | 148,900 | 0.7% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $3.1M | 57,901 | 0.6% |